Could cause temporary or reversible harm; serious harm is unlikely.
Product Mix-up
| Brand name | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
| Generic name | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
| Active ingredient(s) | ACETAMINOPHEN, HYDROCODONE BITARTRATE |
| Distributed by / for | Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 |
| NDC | 31722-997-01 |
| Full product label | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01. |
| Recalling firm | Ascent Pharmaceuticals, Inc. |
| Distribution | USA Nationwide |
| Quantity | 9744 bottles |
| Recall initiated | 2021-11-19 |
| Report date | 2021-12-15 |
| Recall completed | 2023-12-06 |
| Recall number | D-0276-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Central Islip NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗